Eloxx Pharmaceuticals Inc. is a biotechnology company specializing in the development of novel therapeutics for the treatment of genetic diseases caused by nonsense mutations. With a focus on rare diseases, Eloxx is committed to developing innovative solutions to address unmet medical needs and improve patient outcomes.
